AQST
Aquestive Therapeutics, Inc.
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Aquestive Therapeutics, Inc.
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Last report2 of 8 at or beyond impliedshaded = implied▲▼ = realized× = |realized| ÷ implied
Aquestive Therapeutics, Inc.
3.92
−4.08%
vs ±12.4% implied · ×0.33
shaded = implied · ▲▼ = realized
No thesis.
Fund move
Fund move
| Rank | Manager | Value | % 13F | ||
|---|---|---|---|---|---|
| 1 | Bratton Capital ManagementBratton | $40.8M | 13.29% | 0.00% | |
| 2 | BlackRockBlackRockindex-like | $33.6M | 10.93% | +7.46% | |
| 3 | RTW InvestmentsRTW | $30.9M | 10.06% | 0.00% | |
| 4 | Vanguard Capital ManagementVanguardindex-like | $19.1M | 6.21% | +3.17% | |
| 5 | Federated InvestorsFederated Investors | $12.9M | 4.22% | +5.86% | |
| 6 | State StreetState Streetindex-like | $12.2M | 3.97% | +15.00% | |
| 7 | Geode Capital ManagementGeodeindex-like | $10.9M | 3.55% | +8.92% | |
| 8 | Samsara BioCapitalSamsara BioCapital | $10.4M | 3.39% | 0.00% | |
| 9 | Bank of AmericaBank of America | $6.9M | 2.26% | −30.63% | |
| 10 | Sio Capital ManagementSio | $6.2M | 2.01% | −22.71% | |
| 11 | Propel Bio ManagementPropel Bio | $6.0M | 1.95% | +102.87% | |
| 12 | Susquehanna International GroupSusquehanna International | $5.8M | 1.88% | −14.11% | |
| 13 | Wasatch AdvisorsWasatch | $5.8M | 1.88% | +57.78% | |
| 14 | Two Sigma InvestmentsTwo Sigma | $5.3M | 1.74% | +12.45% | |
| 15 | NuveenNuveenindex-like | $5.1M | 1.65% | +379.44% | |
| 16 | Janney Montgomery ScottJanney Montgomery Scott | $4.6M | 1.50% | +1.57% | |
| 17 | Wells FargoWells Fargo | $4.5M | 1.48% | +5.26% | |
| 18 | Commonwealth Equity ServicesCommonwealth Equity Services | $4.4M | 1.42% | −3.37% | |
| 19 | BarclaysBarclays | $4.1M | 1.35% | +24.71% | |
| 20 | Blue Owl Capital HoldingsBlue Owl Capital | $3.9M | 1.28% | −30.05% | |
| 21 | Northern TrustNorthern Trustindex-like | $3.5M | 1.13% | +13.47% | |
| 22 | BNP Paribas ArbitrageBNP Paribas Arbitrage | $3.3M | 1.08% | −1.77% | |
| 23 | Balyasny Asset ManagementBalyasny | $3.1M | 1.01% | −74.33% | |
| 24 | Vanguard Portfolio ManagementVanguard Portfolioindex-like | $3.1M | 0.99% | +6.14% | |
| 25 | Citadel AdvisorsCitadel | $3.0M | 0.96% | −30.27% |
186 managers report $307.1M of Aquestive Therapeutics on form 13F for the quarter ended Jun 30 '26. 24 of them hold 80% of it; Bratton is largest at 13.29%.
Expected move
Inputsspot 3.89exp Nov 20ATM strike 4ATM straddle 0.53IV 69%